ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

127 hedge funds and large institutions have $469M invested in Intra-Cellular Therapies Inc. in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 28 reducing their positions, and 13 closing their positions.

Holders
127
Holders Change
Holders Change %
0%
% of All Funds
2.75%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
52
Reduced
28
Closed
13
Calls
$42.6M
Puts
$4.38M
Net Calls
+$38.2M
Net Calls Change
+$666K
Name Market Value Shares Shares
Change
Shares
Change %
LTFS
126
Ladenburg Thalmann Financial Services
Florida
$2K 150
Point72 Asset Management
127
Point72 Asset Management
Connecticut
-300,352 Closed
FCM
128
Farallon Capital Management
California
-250,000 Closed
PAM
129
Premier Asset Management
Illinois
-63,304 Closed
HI
130
HBK Investments
Texas
-53,534 Closed
BG
131
Bellevue Group
Switzerland
-52,600 Closed
Los Angeles Capital Management
132
Los Angeles Capital Management
California
-51,030 Closed
First Trust Advisors
133
First Trust Advisors
Illinois
-24,087 Closed
AQR Capital Management
134
AQR Capital Management
Connecticut
-19,837 Closed
Group One Trading
135
Group One Trading
Illinois
-19,561 Closed
GCP
136
GSA Capital Partners
United Kingdom
-12,449 Closed
PA
137
Profund Advisors
Maryland
-12,084 Closed
QT
138
Quantbot Technologies
New York
-677 Closed
PHK
139
Point72 Hong Kong
Hong Kong
-19 Closed
GPP
140
Great Point Partners
Connecticut
JGC
141
J. Goldman & Co
New York
SFM
142
Sphera Funds Management
Israel
WAM
143
Wolverine Asset Management
Illinois
BFM
144
Boothbay Fund Management
New York
FIA
145
FNY Investment Advisers
New York
WVP
146
Worth Venture Partners
New Jersey
CFGS
147
Concourse Financial Group Securities
Alabama
Susquehanna International Group
148
Susquehanna International Group
Pennsylvania
HT
149
HAP Trading
New York
DAM
150
DLD Asset Management
New York